Bamco Inc Supernus Pharmaceuticals, Inc. Transaction History

Bamco Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 09, 2018	SELL	$37.15 - $46.9 $2.47 Million - $3.12 Million	-66,561 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $839,384 - $982,356	-23,060 Reduced 25.73%	66,561 $2.65 Million
Q3 2017 Nov 15, 2017	BUY	$36.75 - $49.65 $3.29 Million - $4.45 Million	89,621	89,621 $3.59 Million

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.71B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.